These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 23884270

  • 1. Eculizumab for atypical hemolytic uremic syndrome in pregnancy.
    Ardissino G, Wally Ossola M, Maria Baffero G, Rigotti A, Cugno M.
    Obstet Gynecol; 2013 Aug; 122(2 Pt 2):487-489. PubMed ID: 23884270
    [Abstract] [Full Text] [Related]

  • 2. Innovative therapeutic approach: sequential treatment with plasma exchange and eculizumab in a pregnant woman affected by atypical hemolytic-uremic syndrome.
    Mussoni MP, Veneziano FA, Boetti L, Tassi C, Calisesi C, Nucci S, Rigotti A, Panzini I, Ardissino G.
    Transfus Apher Sci; 2014 Oct; 51(2):134-6. PubMed ID: 25294113
    [Abstract] [Full Text] [Related]

  • 3. Eculizumab in atypical hemolytic uremic syndrome: long-term clinical course and histological findings.
    Tschumi S, Gugger M, Bucher BS, Riedl M, Simonetti GD.
    Pediatr Nephrol; 2011 Nov; 26(11):2085-8. PubMed ID: 21877169
    [Abstract] [Full Text] [Related]

  • 4. Pathogenic Variants in Complement Genes and Risk of Atypical Hemolytic Uremic Syndrome Relapse after Eculizumab Discontinuation.
    Fakhouri F, Fila M, Provôt F, Delmas Y, Barbet C, Châtelet V, Rafat C, Cailliez M, Hogan J, Servais A, Karras A, Makdassi R, Louillet F, Coindre JP, Rondeau E, Loirat C, Frémeaux-Bacchi V.
    Clin J Am Soc Nephrol; 2017 Jan 06; 12(1):50-59. PubMed ID: 27799617
    [Abstract] [Full Text] [Related]

  • 5. Plasma resistant atypical hemolytic uremic syndrome associated with a CFH mutation treated with eculizumab: a case report.
    Sevinc M, Basturk T, Sahutoglu T, Sakaci T, Koc Y, Ahbap E, Akgol C, Kara E, Brocklebank V, Goodship TH, Kavanagh D, Unsal A.
    J Med Case Rep; 2015 Apr 29; 9():92. PubMed ID: 25925370
    [Abstract] [Full Text] [Related]

  • 6. Atypical hemolytic uremic syndrome in first trimester pregnancy successfully treated with eculizumab.
    Andries G, Karass M, Yandrapalli S, Linder K, Liu D, Nelson J, Pawar R, Chugh S.
    Exp Hematol Oncol; 2017 Apr 29; 6():4. PubMed ID: 28101432
    [Abstract] [Full Text] [Related]

  • 7. New treatment options for atypical hemolytic uremic syndrome with the complement inhibitor eculizumab.
    Köse O, Zimmerhackl LB, Jungraithmayr T, Mache C, Nürnberger J.
    Semin Thromb Hemost; 2010 Sep 29; 36(6):669-72. PubMed ID: 20865644
    [Abstract] [Full Text] [Related]

  • 8. Hemolytic Uremic Syndrome in Pregnancy and Postpartum.
    Bruel A, Kavanagh D, Noris M, Delmas Y, Wong EKS, Bresin E, Provôt F, Brocklebank V, Mele C, Remuzzi G, Loirat C, Frémeaux-Bacchi V, Fakhouri F.
    Clin J Am Soc Nephrol; 2017 Aug 07; 12(8):1237-1247. PubMed ID: 28596415
    [Abstract] [Full Text] [Related]

  • 9. Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome.
    Legendre CM, Licht C, Muus P, Greenbaum LA, Babu S, Bedrosian C, Bingham C, Cohen DJ, Delmas Y, Douglas K, Eitner F, Feldkamp T, Fouque D, Furman RR, Gaber O, Herthelius M, Hourmant M, Karpman D, Lebranchu Y, Mariat C, Menne J, Moulin B, Nürnberger J, Ogawa M, Remuzzi G, Richard T, Sberro-Soussan R, Severino B, Sheerin NS, Trivelli A, Zimmerhackl LB, Goodship T, Loirat C.
    N Engl J Med; 2013 Jun 06; 368(23):2169-81. PubMed ID: 23738544
    [Abstract] [Full Text] [Related]

  • 10. [HELLP syndrome and hemolytic uremic syndrome during pregnancy: two disease entities, same causation. Case report and literature review].
    Mancini A, Ardissino G, Angelini P, Giancaspro V, La Raia E, Nisi M, Proscia A, Tarantino G, Vitale O, D'elia F.
    G Ital Nefrol; 2019 Apr 06; 36(2):. PubMed ID: 30983177
    [Abstract] [Full Text] [Related]

  • 11. Atypical hemolytic uremic syndrome.
    Kavanagh D, Goodship TH, Richards A.
    Semin Nephrol; 2013 Nov 06; 33(6):508-30. PubMed ID: 24161037
    [Abstract] [Full Text] [Related]

  • 12. Atypical and secondary hemolytic uremic syndromes have a distinct presentation and no common genetic risk factors.
    Le Clech A, Simon-Tillaux N, Provôt F, Delmas Y, Vieira-Martins P, Limou S, Halimi JM, Le Quintrec M, Lebourg L, Grangé S, Karras A, Ribes D, Jourde-Chiche N, Rondeau E, Frémeaux-Bacchi V, Fakhouri F.
    Kidney Int; 2019 Jun 06; 95(6):1443-1452. PubMed ID: 30982675
    [Abstract] [Full Text] [Related]

  • 13. Eculizumab for the treatment of pregnancy-related atypical hemolytic uremic syndrome.
    Cañigral C, Moscardó F, Castro C, Pajares A, Lancharro A, Solves P, de la Rubia J, Carpio N, Sanz MA.
    Ann Hematol; 2014 Aug 06; 93(8):1421-2. PubMed ID: 24306089
    [No Abstract] [Full Text] [Related]

  • 14. Novel aspects of atypical haemolytic uraemic syndrome and the role of eculizumab.
    Verhave JC, Wetzels JF, van de Kar NC.
    Nephrol Dial Transplant; 2014 Sep 06; 29 Suppl 4():iv131-41. PubMed ID: 25165180
    [Abstract] [Full Text] [Related]

  • 15. Neonatal onset atypical hemolytic uremic syndrome successfully treated with eculizumab.
    Besbas N, Gulhan B, Karpman D, Topaloglu R, Duzova A, Korkmaz E, Ozaltin F.
    Pediatr Nephrol; 2013 Jan 06; 28(1):155-8. PubMed ID: 22956028
    [Abstract] [Full Text] [Related]

  • 16. Hemolytic uremic syndrome with dual caution in an infant: cobalamin C defect and complement dysregulation successfully treated with eculizumab.
    Barlas UK, Kıhtır HS, Goknar N, Ersoy M, Akcay N, Sevketoglu E.
    Pediatr Nephrol; 2018 Jun 06; 33(6):1093-1096. PubMed ID: 29558000
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of eculizumab in a patient with factor-H-associated atypical hemolytic uremic syndrome.
    Lapeyraque AL, Frémeaux-Bacchi V, Robitaille P.
    Pediatr Nephrol; 2011 Apr 06; 26(4):621-4. PubMed ID: 21161283
    [Abstract] [Full Text] [Related]

  • 18. Typical or Atypical Hemolytic Uremic Syndrome and the Use of Eculizumab: 4 Illustrative Cases.
    de Ville de Goyet M, Detaille T, Godefroid N.
    J Pediatr Hematol Oncol; 2019 Oct 06; 41(7):e459-e462. PubMed ID: 30933023
    [Abstract] [Full Text] [Related]

  • 19. Ockham's razor defeated: about two atypical cases of hemolytic uremic syndrome.
    Schwarz C, Brehon A, Mousseaux C, Luque Y, Senet P, Mariani P, Mohamadou I, Zafrani L, Frémeaux-Bacchi V, Rondeau E, Buob D, Rafat C.
    BMC Nephrol; 2020 Jul 11; 21(1):269. PubMed ID: 32652955
    [Abstract] [Full Text] [Related]

  • 20. Eculizumab therapy in a child with hemolytic uremic syndrome and CFI mutation.
    Cayci FS, Cakar N, Hancer VS, Uncu N, Acar B, Gur G.
    Pediatr Nephrol; 2012 Dec 11; 27(12):2327-31. PubMed ID: 22903728
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.